IP Library Granted Patent US 9,546,317
Granted Patent B2
US 9,546,317 · App. 13/920,922 · Granted Jan 17, 2017

Synthesis of water soluble non-toxic nanocrystalline quantum dots and uses thereof

Inventors: Wei-Heng Shih (Bryn Mawr, PA); Wan Y. Shih (Bryn Mawr, PA); Hui Li (Newark, DE)
Assignee: Drexel University
C09K11/565B82Y30/00C01G9/08C01G11/02C01P2002/72C01P2002/82C01P2002/84C01P2004/04C01P2004/64C01P2006/22C01P2006/60Y10T428/2982
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,546,317
App. No.
13/920,922
Granted
Jan 17, 2017
Kind
B2
Abstract

An economic, direct synthetic method for producing water soluble ZnS QDs that are ready for bioconjugation is provided. The method can produce aqueous ZnS QDs with emission wavelengths varying from 400 nm to 700 nm. Highly luminescent metal sulfide (MS) QDs are produced via an aqueous synthesis route. MS QDs are capped with thiol-containing charged molecules in a single step. The resultant MS QDs exhibit the distinctive excitonic photoluminescence desired of QDs and can be fabricated to avoid undesirable broadband emissions at higher wavelengths. The aqueous ZnS QDs are stable in biological fluids over a long period of time. In addition, non-toxic ZnS QDs have been produced with good photoluminescence properties.

Claims (27)

1. A method for making quantum dots suitable for bioconjugation, said method comprising the steps of:

a. providing an aqueous solution of at least one metal salt, and at least one thiol-containing compound other than 3-mercaptopropyltrimethoxysilane;

b. adjusting the pH of the aqueous solution of metal salt and thiol-containing compound to a pH of at least 8;

c. adding a water-soluble sulfide to the aqueous solution of at least one metal salt, and at least one thiol-containing compound to precipitate metal sulfide and form quantum dots having thiol containing capping groups;

d. quenching to about a freezing point of water to form a suspension of quantum dots; and

e. after completion of step d, replacing at least some of the thiol-containing capping groups formed in step c, with a different thiol containing group derived from 3-mercaptopropyltrimethoxysilane.

2. The method as claimed in claim 1 , further comprising the step of:

f. refluxing the quenched suspension for a period of time sufficient to improve the emission intensity of the quantum dots.

3. The method as claimed in claim 1 , wherein the metal sulfide is selected from CdS and ZnS.

4. The method as claimed in claim 1 , wherein the water-soluble sulfide is employed in an amount of about 0.1 to about 10 times the stoichiometric amount of the water-soluble sulfide required to react with the metal salt.

5. The method as claimed in claim 1 , wherein the molar ratio of thiol groups to metal is from about 1 to about 8.

6. The method as claimed in claim 1 , wherein the process is performed in an atmosphere that is substantially free of oxygen.

7. The method as claimed in claim 1 , wherein the metal salt is zinc nitrate, the thiol-containing compound in step c is 3-mercaptopropionic acid and the sulfide is sodium sulfide.

8. The method as claimed in claim 1 , wherein the thiol-containing capping groups of the QDs formed in step c are groups derived from a mercaptocarboxylic acid.

9. The method as claimed in claim 1 , wherein the quantum dots have an emission wavelength in the range of about 410-500 nm.

10. The method as claimed in claim 3 , wherein the quantum dots have an emission wavelength in the range of about 410-440 nm.

11. The method as claimed in claim 1 , wherein the metal salt is selected from the group consisting of Cd(NO 3 ) 2 , Cd(ClO 4 ) 2 , CdCl 2 , CdSO 4 , cadmium acetate, Zn(NO 3 ) 2 , Zn(ClO 4 ) 2 , ZnSO 4 , ZnCl 2 , zinc acetate, Mn(NO 3 ) 2 , Mn(ClO 4 ) 2 , MnSO 4 , MnCl 2 , manganese acetate, Pb(NO 3 ) 2 , Pb(ClO 4 ) 2 , PbSO 4 , PbCl 2 , lead acetate and mixtures thereof.

12. The method as claimed in claim 11 , wherein the water soluble sulfide is selected from the group consisting of as Na 2 S, K 2 S and H 2 S.

13. The method as claimed in claim 1 , wherein the water-soluble sulfide is employed in an amount of about 0.5 to about 5 times the stoichiometric amount of the water-soluble sulfide required to react with the metal salt.

14. The method as claimed in claim 1 , wherein the water-soluble sulfide is employed in an amount of about 0.8 to about 1.2 times the stoichiometric amount of the water-soluble sulfide required to react with the metal salt.

15. The method as claimed in claim 1 , wherein the at least one thiol-containing compound in step c is selected from the group consisting of 4-aminothiophenol, mercaptocarboxylic acids and mixtures thereof.

16. The method as claimed in claim 1 , wherein the at least one thiol-containing compound in step c is selected from the group consisting of mercaptoacetic acid, mercaptopropionic acid, mercaptosuccinic acid, mercaptobenzoic acid, mercaptoundecanoic acid and mixtures thereof.

17. The method as claimed in claim 3 , wherein the metal sulfide is ZnS, and the metal salt, thiol-containing compound and sulfide are employed in an amount which provides a ratio of MPS:Zn:S of from about 0.125:4:1 to about 12:4:1.

18. The method as claimed in claim 1 , wherein the suspension of quantum dots has an emission wavelength in the range of about 400-700 nm.

19. The method as claimed in claim 1 , wherein the 3-mercaptopropyltrimethoxysilane is employed in an amount which provides a ratio of 3-mercaptopropyltrimethoxysilane:sulfide of from about 0.125:1 to about 12:1.

20. The method as claimed in claim 19 , wherein the 3-mercaptopropyltrimethoxysilane is employed in an amount which provides a ratio of 3-mercaptopropyltrimethoxysilane:sulfide of from about 0.5:1 to about 10:1.

21. The method as claimed in claim 20 , wherein the 3-mercaptopropyltrimethoxysilane is employed in an amount which provides a ratio of 3-mercaptopropyltrimethoxysilane:sulfide of from about 1:1 to about 8:1.

Assignments (1)
CONFIRMATORY LICENSE Recorded Nov 10, 2022
From: DREXEL UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 061916/0728 →
Continuity (3)
Division 11943790 · Nov 21, 2007
Provisional Application 60867245 · Nov 27, 2006
Related Publication 20130277614A1 · Oct 24, 2013